Creative Testing Solutions

Creative Testing Solutions is a tax-exempt nonprofit organization headquartered in Tempe, Arizona, that has been registered to receive federal contract and grant awards since April 2010. The organization specializes in comprehensive medical testing and laboratory services, with particular expertise in blood donor screening, infectious disease detection, and biomedical research support across federal healthcare institutions. Creative Testing Solutions maintains demonstrated capabilities in testing for bloodborne pathogens including HIV, hepatitis, syphilis, and other infectious diseases, with the operational capacity to process large sample volumes annually and provide detailed analytical support to military medical centers and federal research programs.

Creative Testing Solutions has secured substantial prime federal contract awards totaling approximately $22.1 million across multiple federal agencies, with the Defense Health Agency serving as its primary contracting partner. Recent prime contract awards from the Defense Health Agency include three five-year purchase orders totaling approximately $8.65 million for blood donor infectious disease testing services at Fort Moore, Georgia; Fort Leonard Wood, Missouri; and William Beaumont Army Medical Center at Fort Bliss, Texas, all with performance periods extending through 2030. The organization also holds a $6.97 million definitive contract with the Defense Health Agency for standard test panel infectious disease testing services at Fort Liberty, North Carolina, with completion through September 2028, and previously held a $2.33 million purchase order for blood donor and transport services. Beyond the Defense Health Agency, Creative Testing Solutions received a $90,000 purchase order from the Centers for Disease Control and Prevention Pittsburgh location for serum services, and a $1 million delivery order from the National Institutes of Health Clinical Center for blood testing solutions. All prime contract awards were executed under full-and-open competition with no small business set-aside designations. Creative Testing Solutions has also participated as a subcontractor on federal projects, including work under Vitalant as prime contractor on the CDC Repeat Donor Cohort Study, performing quantitative immunoglobulin and nucleocapsid testing on thousands of samples at specified per-test rates while contributing research and analytical support.

Creative Testing Solutions maintains an active Indefinite Delivery Contract with the National Institutes of Health Clinical Center valued at $2.96 million, awarded on August 1, 2022, with a period of performance through July 31, 2026. This single-award indefinite delivery contract procures routine blood and donor testing services in support of the NIH's transfusion medicine initiatives and research protocols, including blood donor testing, infectious disease screening, and specialized serum and blood testing. The organization performs all testing at its own facilities or through its network of laboratories, enabling the NIH Clinical Center to efficiently obtain ongoing laboratory services critical to supporting its medical research activities. The contract has included option year exercises, with the current performance period running from August 1, 2025, through July 31, 2026.